Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration
NCT04522999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-09-02
Summary
To evaluate the ability of Photobiomodulation (PBM) treatment using the Valeda® Light Delivery System to improve Electroretinogram (ERG) outcomes in subjects with dry Age-related Macular Degeneration (AMD).
Conditions
- Age Related Macular Degeneration
Interventions
- DEVICE
-
Photobiomodulation
The Valeda™ Light Delivery System
Sponsors & Collaborators
-
LumiThera, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-20
- Primary Completion
- 2021-08-13
- Completion
- 2021-08-13
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies
NCT05976139 ·Status: RECRUITING ·Phase: NA
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD
NCT03968575 ·Status: UNKNOWN ·Phase: NA
-
Photodynamic Therapy for PDA in NV AMD
NCT02452840 ·Status: COMPLETED
-
Laser Intervention in Early Age-Related Macular Degeneration Study
NCT01790802 ·Status: COMPLETED ·Phase: NA
-
Stem Cells Therapy in Degenerative Diseases of the Retina
NCT03772938 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
NCT02465749 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Long Term Follow-Up of Diabetic Retinopathy
NCT00001395 ·Status: COMPLETED
-
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
NCT02314299 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study
NCT02960828 ·Status: UNKNOWN ·Phase: NA
-
Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
NCT07266584 ·Status: RECRUITING ·Phase: NA
-
Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)
NCT00523406 ·Status: COMPLETED ·Phase: PHASE3
-
Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema
NCT03641144 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema
NCT03866473 ·Status: COMPLETED ·Phase: NA
-
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
NCT04359771 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
NCT02638714 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).
NCT00331253 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD
NCT02800356 ·Status: COMPLETED ·Phase: NA
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
NCT01759121 ·Status: UNKNOWN ·Phase: NA
-
Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study
NCT05491746 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Low-Fluence PRP for PDR
NCT01737957 ·Status: TERMINATED ·Phase: NA